Pds Planning, Inc Crispr Therapeutics Ag Transaction History

Pds Planning, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$110.2 - $156.64 $165,300 - $234,959	-1,500 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$100.84 - $161.89 $151,260 - $242,834	1,500 New	1,500 $243,000
Q1 2021 Apr 20, 2021	SELL	$110.72 - $210.04 $166,080 - $315,060	-1,500 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$79.67 - $173.23 $119,505 - $259,844	1,500 New	1,500 $230,000

549

56.3M

2.91M

2.47M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.14B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

Stay updated on Pds Planning, Inc with notifications on news.